Voglinorm 0.3 Tablet
Marketer
Micro Labs Ltd
Salt Composition
Voglibose (0.3mg)
Overview Voglinorm 0.3 Tablet
Diabetol 0.3mg tablets manage type 2 diabetes by regulating postprandial hyperglycemia. This medication is prescribed when dietary changes and other antidiabetic therapies prove insufficient to control elevated blood glucose. Diabetol 0.3mg should be administered immediately before meals; dosage and frequency are determined individually by your physician to optimize glycemic control. Discontinuing this medication abruptly is strongly discouraged as it may trigger dangerously high blood sugar, potentially leading to severe complications such as renal impairment and vision loss. Treatment involves a holistic approach incorporating a balanced diet, regular exercise, and weight management as advised by your doctor, in addition to this medication. Regular blood glucose monitoring is crucial. Common side effects include abdominal discomfort, bloating, appetite changes, bowel irregularities (constipation or diarrhea). Report any persistent or troublesome side effects to your physician. While Diabetol 0.3mg alone doesn't cause hypoglycemia, concurrent use with other antidiabetic agents (especially insulin or sulfonylureas) increases this risk. Treatment for hypoglycemic episodes requires simple glucose; sucrose is ineffective in this context. Prior to commencing treatment, inform your doctor of any hepatic or renal issues. This medication is contraindicated in patients with bowel inflammation or ulceration (e.g., Crohn's disease or ulcerative colitis). Pregnant or lactating individuals should seek medical advice before use. Complete disclosure of all other medications is essential for safe and effective therapy. Limit alcohol consumption while taking Diabetol 0.3mg as it may heighten the risk of hypoglycemia.
Uses of Voglinorm 0.3 Tablet
Managing Type 2 Diabetes
Major Benefits of Voglinorm 0.3 Tablet:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Voglinorm 0.3 Tablet whole; avoid chewing, crushing, or breaking it. Administer on an empty stomach.
Common Side effects of Voglinorm 0.3 Tablet:
- Skin rash
- Flatulence
- Abdominal pain
- Diarrhea
How to use Voglinorm 0.3 Tablet:
Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Voglinorm 0.3 Tablets should be taken on an empty stomach.
How Voglinorm 0.3 Tablet works:
Voglinorm 0.3mg tablets are used to manage diabetes. They work by blocking enzymes in the gut that digest complex carbohydrates into simple sugars like glucose, thus moderating post-meal blood sugar spikes.
SAFETY ADVICE
AlcoholUNSAFE
Combining Voglinorm 0.3 Tablet and alcohol is inadvisable.
PregnancySAFE IF PRESCRIBED
The use of Voglinorm 0.3 Tablet during pregnancy is generally deemed safe. Preclinical trials in animals revealed minimal or no harmful consequences for the fetus; nonetheless, data from human trials are scarce.
Breast feedingSAFE IF PRESCRIBED
Breastfeeding mothers can likely use Voglinorm 0.3 Tablet safely. Available human data indicates minimal infant risk associated with the medication.
DrivingSAFE
Driving ability is typically unaffected by Voglinorm 0.3 Tablet.
KidneyCAUTION
Patients with severe kidney impairment should use Voglinorm 0.3mg tablets cautiously, as dose modification may be necessary. Physician consultation is advised.
LiverCAUTION
Patients with severe hepatic impairment should use Voglinorm 0.3mg tablets cautiously. Dosage modification may be necessary; physician consultation is recommended.
What if you forget to take Voglinorm 0.3 Tablet :
Omit any missed Voglinorm 0.3 Tablet dose and resume your usual medication regimen. Avoid taking a double dose.
Facts to Know About Voglinorm 0.3 Tablet
| Label | Value |
|---|---|
| Chemical Classification | Valiolamine analog |
| Developing Habits | No. |
| Treatment Category | Diabetes medication |
| Action Category | Alpha-glucosidase inhibitors |




